Plasmid constructs and transposons
To construct pCompact-Kana-LacZα ( Supplementary Figure 1) , the N-terminal 150 bp of β-galactosidase gene (lacZα) and the E. coli lactose promoter (Plac) were amplified by PCR and ligated (Supplementary Table 1 ). pCompactKana-CcdB (Supplementary Figure 1) was generated by amplifying the ccdB gene (300 bp) using primers (CcdB-up and CcdB-lo) that contain BsaI sites (Supplementary Table 1 ). To construct pFrameCheck (Supplementary Figure  1) , the E. coli lactose promoter, the gIII signal sequence (40) of the minor capsid protein from the filamentous phage fd, stuffer DNA, and the β-lactamase gene were individually amplified using the indicated primers (Supplementary Table  1 Figure 1) , the Plac and stuffer DNA were amplified using PCR with the indicated primers and ligated (Supplementary Table 1 ). For constructing mutation inserts (MI) (Supplementary Figure 1) , the Zeocin resistance gene cassette and the stuffer DNA were amplified and ligated as indicated (Supplementary Figure 1 and  Supplementary Table 1) . Three incorporating bases (IB) were located in the Zeo-up primers. The IBs in the primers were selected to represent codons for the 20 different amino acids (Supplementary Table 1 ). The stuffer ligated to the Zeocin resistance gene cassette was ligated to a replication origin (Supplementary Figure  1) . Each pMutationInsert containing different IBs was individually constructed. For preparing a mixture of MIs (MI-mix), equal amounts of each vector were mixed and digested with NotI (New England Biolabs, Ipswich, MA, USA) followed by gel purification.
For the Tn7 transposon, pGPS2.1 (New England Biolabs) was modified to contain NotI sites flanking the right (R) and left (L) consensus sequences of Tn7 using PCR with primer #3379 (5′-TGCGGC-CGCACAATAAAGTCTTAAACT-GAACAAAA-3′) and #3382 (5′-TGC-G G CCG C AC A A A ATAG T TG G -GAACTGGGA-3′). A NotI site inside Tn7 was removed. For the Mu transposon, M1-Cam R (Finnzymes, Espoo, Finland) was used.
Mutagenesis
The plasmids containing the transposon in the target gene were digested with NotI to remove the transposon sequence and then gel-purified. The linearized plasmid DNA was ligated with an MI or MI-mix. After electrotransformation of the ligated mixture, the E. coli culture was grown in 50 μg/mL kanamycin and 25 μg/ mL Zeocin (Invitrogen, Carlsbad, CA) to select clones containing the MI. The plasmid was purified and digested with BsgI (New England Biolabs) followed by treatment with T4 DNA polymerase (New England Biolabs) according to the manufacturer's instruction to generate blunt ends. After agarose gel purification, the vector DNA was self-ligated and electrotransformed into E. coli and grown in LB containing 50 μg/mL kanamycin at 37°C overnight with shaking (Excella E24, New Brunswick Scientific, Edison, NJ, USA). The following day, the plasmids were again purified, digested with BpmI (New England Biolabs) followed by the same procedure as for BsgI digestion. For the lacZα mutagenesis, E. coli strain Top10 was used and for the ccdB mutagenesis, DB3.1, which is resistant to the ccdB's cytotoxic activity was used except for the last step of screening for E. coli survival in the presence of inactive ccdB. An error-prone PCR (epPCR) mutagenesis kit (Stratagene, La Jolla, CA, USA) was used according to the manufacturer's instruction for comparison to TDEM. After 40 cycles with primers [epLacZ-up: 5 ′-ATG ATCC ATG G G C ACC AT-G AT TACG G AT TC AC TG G C -3 ′, and epLacZ-lo: 5′-CGCCAACCGGT-TACTGTTGGGAAGGGCGATCG-GTGCG-3′ (underlines indicate NcoI and AgeI sites, respectively)], the amplified PCR band was purified from an agarose gel and digested with NcoI and AgeI. The digested DNA was cloned into the pCompact-Kana vector prepared by digesting pCompact-Kana-LacZα with NcoI and AgeI.
Supplementary Material For:
Transposon-directed base-exchange mutagenesis (TDEM): a novel method for multiple-nucleotide substitutions within a target gene 
St u er g I I I
p C om pac t-K a n a P la c
Stu er

BsaI BsaI
Pl a c-u p The sequences underlined represent restriction enzyme sites as follow. 1: Nco I, 2: Age I, 3: Bsa I, 4: Bsg I, 5: Not I and 6: Bpm I.
The NNN sequence was either GCC, CGC, AAC, GAT, TGC, CAG, GAA, GGC, CAT, ATC, CTG, AAA, ATG, TTT, CCA, AGC, ACC, TGG, TAC or GTG. BpmI and BsgI sites in the MI can be moved to vary the number of bases to be removed from the target. In diagram C, the BpmI and BsgI sites are located at position 0 at left and right ends. These distal BpmI and BsgI sites can be moved up to eight bases toward each end. By moving these sites, the bases to be removed will be altered, as shown in D, because moving the site 1 base nearer the end results in 1 more base being deleted form the target. Furthermore, the BpmI site and the BsgI site can be repositioned independently and the IB sequence can be any length so that a sequence of any length can be introduced between the proximal BpmI and BsgI sites, which are fixed. Therefore, TDEM with MIs containing the distal BpmI and BsgI sites at different positions and with IBs of different sequences can be used to produce diverse mutant libraries. For example, if both BpmI and BsgI sites are at P-8 and the IB is of 11 bases, TDEM will result in an 11-base substitution. If the BpmI and BsgI position are at P-0 and P-8 respectively and the IB is of three bases, the result of TDEM will be a three base substitution. If the BpmI and BsgI sites are at positions P-5 and P-6, respectively, and the IB is of 6 bases, the result of TDEM will be a 6-base substitution. TN, transposon; S, stuffer DNA; Z, Zeocin resistance gene; IB, incorporating bases. The amino acid changes are dependent on the integration site and orientation of the MI. The MI will substitute three bases, which will alter one or two codons. Furthermore, depending on the orientation (A or B) of the MI in the target gene, the sequence found in the mutant will be different. Therefore, if the GCC-MI is used, mutants containing GGC (B) as well as mutants containing GCC (A) will result. In this example, if GCC-MI is used for TDEM, five different mutants will result depending on the frame and orientation of the MI.
Vol. Figure 4 . Analysis of the sites in the ccdB gene attacked by Mu-transposon. Transposition was performed into the ccdB gene using different buffers (A, B, C, and D). The transposon was removed using NotI digestion and the linearized plasmid opened at the site of the integration was labeled with 32 P. Labeled plasmid was then digested with PvuII, which cuts outside of the ccdB gene, resulting in DNA fragments of different sizes. The fragments were analyzed using a 6% polyacrylamide gel containing 5 M urea. 25bp, 25-bp ladder (Invitrogen); 10bp, 10-bp ladder (Invitrogen); A/B/C/D, transposition using buffer A/B/C/D, respectively (see "Materials and methods" section).
